Literature DB >> 13897064

Mechanism of cardiovascular actions of heptanolamines.

J GARRETT, W OSSWALD, M GONCALVES MOREIRA.   

Abstract

It has been suggested that heptaminol and methylheptaminol should be used as myocardial stimulants because they have cardiotonic actions similar to those of cardiac glycosides. However, as these aliphatic amines show definite sympathomimetic effects, the mechanism of their actions on the heart was investigated, in order to determine whether digitalis-like properties are involved in these effects. The pattern of pharmacological actions of heptaminol and methylheptaminol was compared with that of catechol amines, tyramine and k-strophanthin. The influence of atropine, hexamethonium, cocaine and reserpine was also investigated. The results show that both heptanolamines have a long-lasting cardiostimulant action which is abolished by cocaine and absent in reserpine pretreated animals. The pharmacological activity of these drugs may be entirely attributed to an indirect sympathomimetic action of the tyramine type, probably due to release of endogenous catechol amines. None of the experimental findings is consistent with the alleged digitalis-like action of these compounds.

Entities:  

Keywords:  AMINO ALCOHOLS/pharmacology; HEART/pharmacology; SYMPATHOMIMETICS/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 13897064      PMCID: PMC1482155          DOI: 10.1111/j.1476-5381.1962.tb01149.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  22 in total

1.  [Anesthesia of laboratory animals with concentrated solutions of chloralose in 1,2-propanediol].

Authors:  A MALAFAYA-BAPTISTA; M S SIMOES; W OSSWALD
Journal:  C R Seances Soc Biol Fil       Date:  1954-11

2.  [On the point of attack of the indirect action of sympathomimetic amines].

Authors:  H J SCHUEMANN; E WEIGMANN
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1960

3.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

4.  Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol.

Authors:  N C MORAN; M E PERKINS
Journal:  J Pharmacol Exp Ther       Date:  1958-11       Impact factor: 4.030

5.  Responses of the ballistocardiogram in dogs to changes in circulation by administration of substances with cardiovascular action.

Authors:  A W HOITINK; A A KNOOP
Journal:  Acta Physiol Pharmacol Neerl       Date:  1957

6.  Displacement, velocity, and acceleration ballistocardiograms as registered with an undamped bed of ultralow natural frequency. I. Theory and dynamic considerations.

Authors:  M B RAPPAPORT
Journal:  Am Heart J       Date:  1956-10       Impact factor: 4.749

7.  [Effect of some sympathomimetics in heart-lung preparation in rats].

Authors:  E F VON HAXTHAUSEN
Journal:  Arzneimittelforschung       Date:  1955-07

8.  Acceleration ballistocardiography; design, construction, and application of a new instrument.

Authors:  R V ELLIOTT; R G PACKARD; D T KYRAZIS
Journal:  Circulation       Date:  1954-02       Impact factor: 29.690

9.  [The effect of cocaine, guanethidine, reserpine, hexamethonium, tetracaine and psicaine on noradrenalin liberation from the heart].

Authors:  R LINDMAR; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1961

10.  [Cardiotonic, coronary dilator, diuretic and right hypotensive (pulmonary artery and right ventricle) properties of 2-methyl-6 amino-2 heptanol hydrochloride (2831 RP)].

Authors:  G GIRAUD; A LOUBATIERES; H LATOUR
Journal:  Presse Med       Date:  1950-10-21       Impact factor: 1.228

View more
  2 in total

1.  On the mode of action of heptaminol.

Authors:  H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

2.  Alteration of the L-type calcium current in guinea-pig single ventricular myocytes by heptaminol hydrochloride.

Authors:  N Peineau; K G Mongo; J Y Le Guennec; D Garnier; J A Argibay
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.